BRAIN-DAMAGE FROM I-125 BRACHYTHERAPY EVALUATED BY MR IMAGING, A BLOOD-BRAIN-BARRIER TRACER, AND LIGHT AND ELECTRON-MICROSCOPY IN A RAT MODEL

被引:29
作者
BERNSTEIN, M
MAROTTA, T
STEWART, P
GLEN, J
RESCH, L
HENKELMAN, M
机构
[1] TORONTO WESTERN HOSP, DIV NEUROSURG, TORONTO M5T 2S8, ONTARIO, CANADA
[2] TORONTO WESTERN HOSP, DIV NEUROPATHOL, TORONTO M5T 2S8, ONTARIO, CANADA
[3] UNIV TORONTO, DEPT ANAT, TORONTO M5S 1A1, ONTARIO, CANADA
[4] UNIV TORONTO, DEPT RADIOL, TORONTO M5S 1A1, ONTARIO, CANADA
[5] UNIV TORONTO, DEPT MED BIOPHYS, TORONTO M5S 1A1, ONTARIO, CANADA
关键词
blood-brain barrier; brain damage; horseradish peroxidase; interstitial brachytherapy; magnetic resonance imaging; rat;
D O I
10.3171/jns.1990.73.4.0585
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Changes in normal rat brain were studied acutely, and at 3, 6, 9, and 12 months following interstitial brachytherapy with high-activity 125I seeds. An 80-Gy radiation dose was administered to an area with a 5.5-mm radius. Effects were measured with magnetic resonance (MR) imaging (with and without gadolinium enhancement), leakage of horseradish peroxidase (HRP), electron microscopy, and light microscopy. Significant histological damage was seen at radiation doses above 295 Gy, and breakdown of the blood-brain barrier was observed only in tissue receiving a dose of 165 Gy or greater. Blood-brain barrier breakdown increased up to the 6-month time point, and thereafter appeared to stabilize or decrease. The area of blood-brain barrier disruption indicated by gadolinium-enhanced MR imaging was greater than that indicated by leakage of HRP.
引用
收藏
页码:585 / 593
页数:9
相关论文
共 41 条
  • [1] REOPERATION IN THE TREATMENT OF RECURRENT INTRACRANIAL MALIGNANT GLIOMAS
    AMMIRATI, M
    GALICICH, JH
    ARBIT, E
    LIAO, Y
    [J]. NEUROSURGERY, 1987, 21 (05) : 607 - 614
  • [2] REGROWTH PATTERNS OF GLIOBLASTOMA-MULTIFORME RELATED TO PLANNING OF INTERSTITIAL BRACHYTHERAPY RADIATION-FIELDS
    BASHIR, R
    HOCHBERG, F
    OOT, R
    [J]. NEUROSURGERY, 1988, 23 (01) : 27 - 30
  • [3] INTERSTITIAL BRACHYTHERAPY FOR MALIGNANT BRAIN-TUMORS - PRELIMINARY-RESULTS
    BERNSTEIN, M
    LAPERRIERE, N
    LEUNG, P
    MCKENZIE, S
    [J]. NEUROSURGERY, 1990, 26 (03) : 371 - 380
  • [4] I-125 INTERSTITIAL IMPLANTS IN THE RIF-1 MURINE FLANK TUMOR - AN ANIMAL-MODEL FOR BRACHYTHERAPY
    BERNSTEIN, M
    GUTIN, PH
    WEAVER, KA
    DEEN, DF
    BARCELLOS, MH
    [J]. RADIATION RESEARCH, 1982, 91 (03) : 624 - 637
  • [5] INTERSTITIAL IRRADIATION OF SKULL BASE TUMORS
    BERNSTEIN, M
    GUTIN, PH
    [J]. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1985, 12 (04) : 366 - 370
  • [6] BERNSTEIN M, 1989, CAN J NEUROL SCI, V16, P237
  • [7] INTERSTITIAL IRRADIATION OF BRAIN-TUMORS - A REVIEW
    BERSTEIN, M
    GUTIN, PH
    [J]. NEUROSURGERY, 1981, 9 (06) : 741 - 750
  • [8] CONTRAST AGENTS IN MAGNETIC-RESONANCE IMAGING
    CARR, DH
    GADIAN, DG
    [J]. CLINICAL RADIOLOGY, 1985, 36 (06) : 561 - 568
  • [9] GADOLINIUM-DTPA AS A CONTRAST AGENT IN MRI - INITIAL CLINICAL-EXPERIENCE IN 20 PATIENTS
    CARR, DH
    BROWN, J
    BYDDER, GM
    STEINER, RE
    WEINMANN, HJ
    SPECK, U
    HALL, AS
    YOUNG, IR
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 1984, 143 (02) : 215 - 224
  • [10] APPLICATION OF CONTRAST AGENTS IN CT AND MRI (NMR) - THEIR POTENTIAL IN IMAGING OF BRAIN-TUMORS
    CLAUSSEN, C
    LANIADO, M
    KAZNER, E
    SCHORNER, W
    FELIX, R
    [J]. NEURORADIOLOGY, 1985, 27 (02) : 164 - 171